Status:
RECRUITING
Screening and Secondary Prevention Rheumatic Heart Disease Study
Lead Sponsor:
National Institute of Cardiovascular Diseases, Pakistan
Conditions:
Rheumatic Heart Disease
Eligibility:
All Genders
10-30 years
Brief Summary
After basic clinical screening including history and physical, Point of care ultrasound will be performed to look at Mitral, Aortic and Tricuspid Valves for regurgitation or stenosis. For patients wit...
Detailed Description
Screening for RHD should be carried out since it is a major health concern that has been shown to have a treatable and detectable latent stage that can be diagnosed using a simple sensitive test (poin...
Eligibility Criteria
Inclusion
- Rural communities in Sindh
Exclusion
- Refused to participate in the study
Key Trial Info
Start Date :
September 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05991219
Start Date
September 26 2022
End Date
December 31 2028
Last Update
August 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Cardiovascular Diseases (NICVD)
Karachi, Sindh, Pakistan, 75510